Which mitigation technique is commonly used to reduce LASA medication errors?

• A. Lower-case lettering to reduce emphasis.
• B. Tall-man lettering to highlight differences between similar-sounding or similar-looking drug names.
• C. Increasing dose strength on labels.
• D. Removing all warnings from labels.

Answer: (B)

Mitigating look-alike/sound-alike medication errors relies on making similar drug names visually distinct. Tall-man lettering uses mixed case to emphasize the parts of names that differ, so staff can more easily notice and distinguish potentially confusing look-alike names at critical moments like prescribing, dispensing, and administration. This direct visual cue helps reduce the chance of selecting the wrong drug when names are similar, which is precisely the risk that LASA errors exploit.

This approach is widely recommended and implemented because it targets the specific issue of name similarity without changing other safety factors. Other options don’t address the core problem: using lowercase removes the visual emphasis on differences, increasing potential mix-ups; increasing dose strength on labels doesn’t resolve name confusion and could mislead; removing warnings massively raises risk by removing safety information.